Press release
Peraso Inc. (NASDAQ: PRSO): Intro-Act Targets $3.30 Per Share After Positive Q3 Performance see more stocks inside....
Intro-Act has set a price target of $3.30 for Peraso Inc. (NASDAQ: PRSO) following the company's Q3 2024 earnings report. The firm maintains a buy rating, emphasizing Peraso's strong financial performance and promising growth trajectory.On November 14, Peraso announced its third fiscal quarter results, highlighting a positive outlook. Revenue aligned with management's expectations, while operational efficiency improved by 20% year-over-year. Notably, operating expenses declined by 34% year-over-year, reflecting the success of the company's cost-reduction initiatives.
Peraso's products continued to gain global traction, with increased adoption in Africa, South Korea, North America, and Europe. The company's customer diversification strategy showed results, converting nine design engagements into new client introductions. Furthermore, 95% of Peraso's clientele are well-established WISPs (wireless internet service providers), underscoring the acceptance of its technology within the industry. Read Entire Report. [https://thestreetreports.com/wp-content/uploads/2024/11/PRSO-Inter-Act-Report.pdf]
The company also achieved significant milestones in fixed wireless access (FWA) for military communications and transportation. Its DUNE platform secured a $1.4 million follow-on order from a South African WISP, further demonstrating demand for its solutions.
Looking ahead, Peraso projects double-digit year-over-year revenue growth in the second half of 2024, outpacing the first half. The Intro-Act report highlighted Peraso's robust sales pipeline, which could lead to major order wins and reinforce its leadership in the mmWave technology sector.
Several innovative Nasdaq-listed companies in additional to Peraso Inc. (NASDAQ: PRSO), are capturing the attention of investors this week with transformative initiatives that reflect their growth potential and industry impact, spanning technology, energy, healthcare and biotech.
* Quantum Computing Inc. (NASDAQ: QUBT): Secured $40M through a direct offering to fund debt repayment, working capital, and corporate growth.
* Aclaris Therapeutics Inc. (NASDAQ: ACRS): Entered a $40M global licensing deal for two cutting-edge immunology assets, $900M potential milestone payments.
* Interactive Strength Inc. (NASDAQ: TRNR): Expands CLMBR fitness equipment in Saudi Arabia through installations at Armah Sports Group's B_FIT locations.
* Alternus Clean Energy Inc. (NASDAQ: ALCE): Improved shareholder equity by $4M and eliminated $30M in debt through the sale of SPVs to its majority shareholder.
From groundbreaking technologies to strategic partnerships and financial advancements, these companies are driving innovation and reshaping their respective industries. They are essential additions to any watchlist for investors seeking dynamic opportunities.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-inc-nasdaq-prso-introact-targets-330-per-share-after-positive-q3-performance-see-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peraso Inc. (NASDAQ: PRSO): Intro-Act Targets $3.30 Per Share After Positive Q3 Performance see more stocks inside.... here
News-ID: 3746972 • Views: …
More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
More Releases for Peraso
Undervalued Tech: Peraso Inc's (NASDAQ: PRSO) True Value Signals Upside - More S …
Mobix Labs recently made the kind of mistake that reveals more about the bidder than the target. Their unsolicited acquisition [https://www.stocktitan.net/news/PRSO/peraso-confirms-receipt-of-unsolicited-non-binding-acquisition-pevb9rjomb71.html] offer for Peraso represents classic bottom-feeding behavior. A 20% premium that exploits market pressure rather than recognizing strategic value.
This follows their established pattern of lowball offers to multiple companies. Mobix declined to sign standard confidentiality agreements, indicating they never intended serious due diligence. The timing reveals everything. PerasoInc's (NASDAQ:…
Peraso (NASDAQ: PRSO) Volume Surges on Takeover News - More Stocks Inside
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company's 30-day average share price.
The proposed merger would create a stronger player in the high-growth mmWave, defense, and 5G semiconductor sectors-combining Mobix's $10.7M revenue base and ~450% YoY growth with Peraso's accelerating mmWave performance. The combined company is expected to generate…
Peraso (NASDAQ: PRSO) Powers Drone Tech Surge in Defense, eVTOL, Aerospace - Mor …
Peraso Inc. (NASDAQ: PRSO) is rapidly emerging as a dominant force in next-generation wireless communications, driven by its advanced mmWave connectivity solutions. Designed for drones and autonomous systems that demand real-time, low-latency data transfer, Peraso's technology is increasingly viewed as foundational to high-performance operations across the defense, aerospace, and mobility sectors.
As the electric aviation and eVTOL (electric vertical takeoff and landing) market gains traction in the U.S., Peraso's ultra-fast wireless…
Peraso Inc.'s (NASDAQ: PRSO) Beamforming Technology Gains Military Traction - Se …
Peraso Inc.'s (NASDAQ: PRSO) advanced beamforming technology has proven to be a game-changer in military and dense urban deployments, where secure, reliable, and high-performance communication is critical. Beamforming's ability to direct signals with precision and bend them around obstacles not only maximizes efficiency but also makes transmissions exceptionally difficult to detect or intercept. These stealth capabilities, combined with Peraso's proprietary innovations, have enabled its solutions to excel in active war…
Peraso Inc.'s (NASDAQ: PRSO) PERSPECTUS Modules Outperform in 60Ghz FWA Market
Introduction
As high-speed internet access spreads around the world, the unlicensed 60GHz (57-71 Ghz) millimeter-wave (mmWave) spectrum offers immense potential for low-cost, low-capex, easily-deployed high-speed wireless communication, especially areas currently underserved by traditional broadband distribution-fiberoptic. Further, However, until recently, purchasing devices to adequately provide mmWave communications for 60Ghz/mmWave broadband deployments has been difficult. Peraso and several other companies have developed and ramped up mass manufacturing of viable 60Ghz solutions for this…
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, …
On Tuesday, June 11th, Peraso Inc. (NASDAQ: PRSO) Director Ian McWalter acquired 100,000 shares of the company's stock at an average price of $1.27 per share, totalling $127,000. This strategic investment increases McWalter's holdings to 101,246 shares.
Image: https://www.abnewswire.com/uploads/9a500d398df4ec1d757968c73f802240.jpg
On June 12, 2024, Ladenburg Thalmann, a renowned Wall Street firm since 1876, initiated coverage [https://thestreetreports.com/wp-content/uploads/2024/06/PRSO-Updated-research.pdf] of Peraso Inc. (NASDAQ: PRSO). Research by Grandview Research in January 2024 highlighted the global mmWave market's…